Selected Publications

Banerjee, R., Ibrahim, KD., Swed, B., Torp, K., Srinath, A., Buckley, R., Bird, A., & Myers, JS.: Transforming Patient Safety Education for Trainees Using Miller's Pyramid as a Framework. HUP Department of Medicine Research Day 2018 Notes: Poster Presentation.

Miller TP, Troxel AB, Li Y, Huang YS, Alonzo TA, Gerbing RB, Hall M, Torp K, Fisher BT, Bagatell R, Seif AE, Sung L, Gamis A, Rubin D, Luger S, Aplenc R.: Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group. Pediatr Blood Cancer. 62(7): 1184-1189, Jul 2015 Notes: doi: 10.1002/pbc.25475.

Seif AE, Walker DM, Li Y, Huang YS, Kavcic M, Torp K, Bagatell R, Fisher BT, Aplenc R.: Dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric oncology patients. Pediatr Blood Cancer. 62(4): 704-709, Apr 2015 Notes: doi: 10.1002/pbc.25043.

Fisher BT, Sammons JS, Li Y, de Blank P, Seif AE, Huang YS, Kavcic M, Klieger S, Harris T, Torp K, Rheam D, Shah A, Aplenc R.: Variation in Risk of Hospital-Onset Clostridium difficile Infection Across β-Lactam Antibiotics in Children With New-Onset Acute Lymphoblastic Leukemia. J Pediatric Infect Dis Soc. 3(4): 329-335, Dec 2014 Notes: doi: 10.1093/jpids/piu008.

Seif AE, Fisher BT, Li Y, Torp K, Rheam DP, Huang YS, Harris T, Shah A, Hall M, Fieldston ES, Kavcic M, Vujkovic M, Bailey LC, Kersun LS, Reilly AF, Rheingold SR, Walker DM, Aplenc R.: Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemia. Pediatr Blood Cancer. 6(5): 846-852, May 2014 Notes: doi: 10.1002/pbc.24855.

Maude SL, Fitzgerald JC, Fisher BT, Li Y, Huang YS, Torp K, Seif AE, Kavcic M, Walker DM, Leckerman KH, Kilbaugh TJ, Rheingold SR, Sung L, Zaoutis TE, Berg RA, Nadkarni VM, Thomas NJ, Aplenc R.: Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States. Pediatr Crit Care Med. 15(2): 112-120, Feb 2014 Notes: doi: 10.1097/PCC.0000000000000042.

Fisher BT, Kavcic M, Li Y, Seif AE, Bagatell R, Huang YS, Zaoutis T, Torp K, Leckerman KH, Aplenc R.: Antifungal prophylaxis associated with decreased induction mortality rates and resources utilized in children with new-onset acute myeloid leukemia. Clin Infect Dis. 58(4): 502-508, Feb 2014 Notes: doi: 10.1093/cid/cit781.

Fisher BT, Harris T, Torp K, Seif AE, Shah A, Huang Yuan-Shung V, Bailey LC, Kersun LS, Reilly AF, Rheingold SR, Walker D, Li Yi, Aplenc R.: Establishment of an 11-year cohort of 8733 pediatric patients hospitalized at United States free-standing children's hospitals with de novo acute lymphoblastic leukemia from health care administrative data. Medical care. 52(1): e1-6, Jan 2014 Notes: doi: 10.1097/MLR.0b013e31824deff9.

Lothstein K, Fisher B, Li Y, Seif A, Harris T, Torp K, Kavcic M, Huang YS, Rheingold SR, Aplenc R.: Zoonotic infections in pediatric patients with acute leukemia. Pediatr Blood Cancer. 60(12): e160-2, Dec 2013 Notes: doi: 10.1002/pbc.24596.

Fisher BT, Gerber JS, Leckerman KH, Seif AE, Huang YS, Li Y, Harris T, Torp K, Douglas R, Shah A, Walker D, Aplenc R.: Variation in hospital antibiotic prescribing practices for children with acute lymphoblastic leukemia. Leuk Lymphoma. 54(8): 1633-39, Aug 2013 Notes: doi: 10.3109/10428194.2012.750722.